Reference : Obesite et diabete de type 2.
Scientific journals : Article
Human health sciences : Endocrinology, metabolism & nutrition
http://hdl.handle.net/2268/10835
Obesite et diabete de type 2.
French
[en] Obesity and type 2 diabetes
Rorive, Marcelle mailto [Centre Hospitalier Universitaire de Liège - CHU > > Diabétologie,nutrition, maladies métaboliques >]
Letiexhe, Michel [Centre Hospitalier Universitaire de Liège - CHU > > Diabétologie,nutrition, maladies métaboliques >]
Scheen, André mailto [Université de Liège - ULg > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale >]
Ziegler, O. [> > > >]
2005
Revue Médicale de Liège
60
5-6
Le diabète sucré dans tous ses états
374-82
Yes (verified by ORBi)
0370-629X
Belgium
[en] Abdomen ; Adipose Tissue ; Diabetes Mellitus, Type 2/etiology/physiopathology ; Diet ; Exercise ; Humans ; Insulin Resistance ; Obesity/complications ; Risk Factors ; Weight Loss
[en] Obesity is an epidemic disease associated with numerous cardiovascular risk factors as diabetes mellitus, dyslipidemia, hypertension. Insulin resistance seems to be an important promoter for the development of most of these abnormalities. Besides genetic background, obesity, especially abdominal adiposity, is by far the most important factor for the development of type 2 diabetes. The treatment of a diabetic obese subject begins with diet and regular physical activity, eventually with a psychological support. In case of failure of such lifestyle approach alone, addition of drug therapy should be considered. It may include pharmacological agents able to promote weight loss (orlistat, sibutramine, possibly rimonabant) and/or antihyperglycaemic compounds capable of reducing insulin resistance (metformin, glitazones, acarbose). In case of severe/morbid obesity complicated with type 2 diabetes not well controlled with medical means, bariatric surgery is the only treatment that can induce an important and sustained weight loss, associated with marked improvement of metabolic control and amelioration of overall prognosis.
Researchers ; Professionals ; Students
http://hdl.handle.net/2268/10835
http://www.rmlg.ulg.ac.be

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
20050506_21.pdfNo commentaryPublisher postprint540.69 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.